IntraLase

IntraLase was a medical-technology company based in Irvine, California, focused on laser systems for medical applications and eye surgery. Its principal legacy is a femtosecond laser developed for corneal surgery. The technology enabled surgeons to create the corneal flap used in a form of laser-assisted in situ keratomileusis, commonly identified with the IntraLASIK name, rather than relying solely on a mechanical microkeratome. The IntraLase name therefore functioned both as a company identity and as a technology brand in ophthalmology. The femtosecond laser was trademarked under the IntraLase name and became the defining product associated with the business. Available reference material does not establish the company's founding year, founder, detailed product portfolio, geographic sales footprint, or executive roster, so those details are left unspecified. In March 2007, Advanced Medical Optics acquired IntraLase for $808 million in cash. The transaction transferred the company and its technology into a larger ophthalmic-device business. Advanced Medical Optics was itself acquired by Abbott Laboratories in February 2009. Following these transactions, IntraLase ceased to operate as an independent company, while the IntraLase trademark and the associated femtosecond-laser technology became part of the acquiring corporate structure. The available material does not document the subsequent commercial life, product revisions, or current trademark status in sufficient detail to describe them reliably.

IntraLase was a company headquartered in Irvine, California, that produced laser equipment for medical applications, with its best-known work directed toward eye surgery. The company's defining technology was a femtosecond laser. In ophthalmic surgery, femtosecond lasers can be used to create the corneal flap required for LASIK, replacing or supplementing the use of a mechanical cutting instrument. IntraLase's technology became associated with the procedure marketed or described as IntraLASIK. The IntraLase name was also used as a trademark for the femtosecond laser developed by the company. This gave the business a technology-centered identity in the ophthalmic-device sector: rather than being known primarily as a broad consumer healthcare brand, it was identified with a specific laser platform and its application in refractive eye surgery. The available reference material does not provide a reliable founding date, founder, detailed account of early research and development, or a complete list of models and markets. Those fields remain undocumented here. A major turning point came in March 2007, when Advanced Medical Optics acquired IntraLase for $808 million in cash. The acquisition ended IntraLase's independence and placed its femtosecond-laser business within a larger company active in ophthalmic products. The transaction was significant because it converted IntraLase from an independent specialist into part of a broader medical-device portfolio. In February 2009, Abbott Laboratories acquired Advanced Medical Optics. Through that parent-level transaction, Abbott became the owner of the former IntraLase business and its associated technology. IntraLase is consequently best understood as a defunct standalone company whose name survives in connection with the trademarked femtosecond-laser technology and the IntraLASIK procedure. The supplied sources do not establish whether the trademark continued under the same commercial strategy, which specific products remained available, or how the business was organized after Abbott's acquisition.

• 2009

  Indirect acquisition by Abbott Laboratories

  [1]IntraLaseen.wikipedia.org

  Abbott Laboratories acquired Advanced Medical Optics in February 2009 and thereby obtained the former IntraLase business and technology.

• 2007

  Acquisition by Advanced Medical Optics

  [1]IntraLaseen.wikipedia.org

  Advanced Medical Optics acquired IntraLase in March 2007 for $808 million in cash, ending IntraLase's status as an independent company.

Ophthalmic laser technology focused on femtosecond laser-assisted corneal surgery and the creation of LASIK corneal flaps.

• Ophthalmic surgical laser

  IntraLase femtosecond laser

  The IntraLase femtosecond laser was the company's signature medical device and was developed for eye surgery. Its principal application was creating the corneal flap used in LASIK, supporting the procedure associated with the IntraLASIK name. The technology was trademarked under IntraLase and became the central product identity of the company.

• 2009

  Transfer into Abbott LaboratoriesM&A

  Background

  Advanced Medical Optics owned IntraLase after the 2007 acquisition.

  Action taken

  Abbott Laboratories acquired Advanced Medical Optics in February 2009.

  Aftermath

  The former IntraLase business and its technology became part of Abbott's corporate ownership structure.

  Source

• 2007

  Sale to Advanced Medical OpticsM&A

  Background

  IntraLase operated as a specialist developer of femtosecond-laser systems for medical and eye-surgery applications.

  Action taken

  Advanced Medical Optics purchased IntraLase in March 2007 in a cash transaction valued at $808 million.

  Aftermath

  IntraLase ceased to be an independent company and became part of Advanced Medical Optics' ophthalmic-device business.

  Acquisition value. $808 million cash consideration (March 2007)

  Source

• 2009

  Abbott Laboratories acquired Advanced Medical Optics[1]IntraLaseen.wikipedia.org

  M&A

  Abbott Laboratories acquired Advanced Medical Optics in February 2009, indirectly bringing the former IntraLase business and its technology into Abbott's ownership.

• 2007

  Advanced Medical Optics acquired IntraLase for $808 million[1]IntraLaseen.wikipedia.org

  M&A

  Advanced Medical Optics announced the acquisition of IntraLase in March 2007 in an all-cash transaction valued at $808 million. The deal brought IntraLase's femtosecond-laser technology for eye surgery into Advanced Medical Optics.

1. 1IntraLaseen.wikipedia.org